Centogene NV
NASDAQ:CNTG
Centogene NV
Common Stock
Centogene NV
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centogene NV
NASDAQ:CNTG
|
Common Stock
€3.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Common Stock
€248.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Common Stock
€37.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
CureVac NV
NASDAQ:CVAC
|
Common Stock
€26.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
107%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Common Stock
€847k
|
CAGR 3-Years
12%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Common Stock
€39.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
See Also
What is Centogene NV's Common Stock?
Common Stock
3.5m
EUR
Based on the financial report for Dec 31, 2023, Centogene NV's Common Stock amounts to 3.5m EUR.
What is Centogene NV's Common Stock growth rate?
Common Stock CAGR 5Y
63%
Over the last year, the Common Stock growth was 5%. The average annual Common Stock growth rates for Centogene NV have been 9% over the past three years , 63% over the past five years .